Should Biotechnology Stock Ambrx Biopharma Inc (AMAM) Be in Your Portfolio Monday?

Monday, October 23, 2023 09:38 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Ambrx Biopharma Inc (AMAM) Be in Your Portfolio Monday?

Ambrx Biopharma Inc (AMAM) is around the top of the Biotechnology industry according to InvestorsObserver. AMAM received an overall rating of 72, which means that it scores higher than 72 percent of all stocks. Ambrx Biopharma Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 72 out of the 148 industries.

AMAM has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on AMAM!

See Full AMAM Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Ambrx Biopharma Inc Stock Today?

Ambrx Biopharma Inc (AMAM) stock is trading at $7.50 as of 9:37 AM on Monday, Oct 23, a decline of -$0.93, or -11.03% from the previous closing price of $8.43. The stock has traded between $7.25 and $7.64 so far today. Volume today is below average. So far 338,801 shares have traded compared to average volume of 1,076,976 shares. Click Here to get the full Stock Report for Ambrx Biopharma Inc stock.